CRISPR

CRISPR1-il10ra

ID
ZDB-CRISPR-230622-3
Name
CRISPR1-il10ra
Previous Names
None
Target
Sequence
5' - GTGTTTTGGTCGGGTGTGGT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
psi71 il10ra
Expression
Gene expression in Wild Types + CRISPR1-il10ra
No data available
Phenotype
Phenotype resulting from CRISPR1-il10ra
No data available
Phenotype of all Fish created by or utilizing CRISPR1-il10ra
Phenotype Fish Conditions Figures
neuromast macrophage il4r.1 expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage il4r.1 expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast hair cell synapse assembly decreased process quality, abnormal il10rapsi71/psi71; stat6xt53/xt53 chemical treatment by environment: neomycin Fig. 5 with image from Denans et al., 2022
neuromast macrophage Ab2-vamp2 labeling decreased amount, abnormal il10rapsi71/psi71; stat6xt53/xt53 chemical treatment by environment: neomycin Fig. 5 with image from Denans et al., 2022
Citations